Home Market Trends /C O R R E C T I O N — Wooree Group/
Market Trends

/C O R R E C T I O N — Wooree Group/

Share
Share

In the news release, Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims, issued 07-Sep-2026 by Wooree Group over PR Newswire, we are advised by the company that the product name "Harutin" should read "Haroutine" throughout the release, as originally issued inadvertently. The complete, corrected release follows:

SEOUL, South Korea and BANGKOK, Thailand, Sept. 7, 2026 /PRNewswire/ — Wooree Group, a leader in biotechnology and lighting solutions with 60 years of expertise, successfully concluded its participation in Vitafoods Asia 2026, held September 2–4 in Bangkok, showcasing its proprietary liposome technology and integrated bio value chain.

Wooree Group's booth at Vitafoods Asia 2026 in Bangkok, Thailand.
Wooree Group’s booth at Vitafoods Asia 2026 in Bangkok, Thailand.

Participating for the second consecutive year, Wooree Group presented its end-to-end bio ecosystem, uniting Wooree Green Science (ingredients), Wooree Bio (manufacturing), and consumer brands Haroutine and Clarion. The booth also received the Silver Award at the Sustainability Booth Design Awards, organized by Informa Markets, in recognition of its eco-friendly structure, reusable materials, and waste-reduction measures.

During a briefing session on scientific validation standards for the liposome market, Wooree Group CEO Ji-yong Yoon noted that despite rapid market growth, objective standards for evaluating product quality remain lacking.

"In the absence of clear industry standards, some products are marketed as ‘liposomal’ simply because particle size was measured or phospholipids are present," Yoon said. "To build genuine trust, a step-by-step validation process is needed from confirming actual liposome formation to demonstrating in-vivo delivery potential."

Yoon introduced Wooree Group’s proposed validation framework, the "Six Pillars," comprising:

"The liposome market should evolve toward a model where competitiveness is determined by how rigorously a product has been validated," Yoon added.

Based on this framework, Wooree Green Science has developed its proprietary liposomal ingredient brand, LIPOPRIME, which encompasses approximately 40 ingredients, including Vitamin C, glutathione, omega-3, and curcumin. NTA analysis demonstrated that select LIPOPRIME ingredients feature particle concentrations up to 24 times higher than competing market alternatives.

Wooree Group is also accelerating its global expansion, having introduced test products from its health functional food brand Haroutine on Amazon in the United States, while collaborating with a plant-cell biotechnology firm on next-generation functional ingredients. Moving forward, the Group plans to further expand strategic partnerships across Southeast Asia and the broader global nutraceutical market.

About Wooree Group
Wooree Group is a diversified manufacturing leader with a 60-year heritage dating back to its founding as Poongwoo Industrial in 1966. Today, the Group operates across two core business pillars: advanced lighting technology and bio-healthcare. Having spearheaded innovations in the lighting and display sectors, including developing Korea’s first "Jangsoo Lamp" and securing the global No. 1 market share in CCFL shipments, Wooree Group expanded into bio-healthcare in 2019. Through affiliates including Wooree Enterprise, Wooree Bio, Wooree E&L, Haroutine, Wooree Green Science, and New Optics, the Group remains dedicated to enhancing human well-being through light and health.

 

Source from: Read the full article

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Market Trends

As Da Nang's MICE Ambitions Rise, Courtyard by Marriott Danang Han River Puts a New Spin on Business Events

DA NANG, Vietnam, Oct. 9, 2026 /PRNewswire/ — Business events are becoming...

Market Trends

Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development

SHANGHAI, Oct. 9, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or...

Market Trends

UOB Asset Management Highlights Opportunities Amid Shifting Global Policy Landscape

SINGAPORE, Oct. 9, 2026 /PRNewswire/ — UOB Asset Management (UOBAM) has released...

Market Trends

AIRA Factoring Surpasses THB 1 Billion in Digital Supply Chain Financing, Powered by NEC Thailand

BANGKOK, Oct. 9, 2026 /PRNewswire/ — AIRA Factoring Public Company Limited has...

Market Trends

Ucommune Announces Extraordinary General Meeting

BEIJING, Oct. 8, 2026 /PRNewswire/ — Ucommune International Ltd (Nasdaq: UK) ("we", "Ucommune"...

Market Trends

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

TAIZHOU, China, Oct. 8, 2026 /PRNewswire/ — China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)...

Market Trends

Visionary Pathway: The Enduring Voice of Minju Opera

FUZHOU, China, Oct. 8, 2026 /PRNewswire/ — A news report from China...